Emergent Biosolutions Inc

NYSE:EBS  
64.35
+0.70 (+1.10%)
Products

FDA Approves Additional Batch Of J&J's U.S.-Made Covid-19 Vaccine For Use

Published: 07/13/2021 18:41 GMT
Emergent Biosolutions Inc (EBS) - :fda Approves Additional Batch of J&j's U.S.-made Covid-19 Vaccine for Use.